Moneycontrol.com Celgene International Sàrl announced that the US Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Ap...
pharmabiz.com In April 2013, the European Medicines Agency (EMA) has also accepted for review a Type II Variation to the current Marketing Authorization Application (MAA...
pharmabiz.com This trial will be the seventh randomized phase II clinical trial evaluating OGX-427 in the treatment of advanced cancers and will investigate whether adding OGX-427 to gemcitabine and carboplatin therapy can extend progression-free survival (PFS) ...
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
Pharmaceutical Business Review ... of patients with advanced pancreatic cancer. In April 2013, the European Medicines Agency also accepted Marketing Authorization Application for Abraxane, in combination with gemcitabine , for the first-line treatment of advanced pancreatic cancer ...
Seeking Alpha Amgen Inc. (AMGN) failed a trial with AMG 479 [ganitumab] late last summer. Both were in combination with gemcitabine . Infinity Pharmaceuticals Inc. (INFI) had a drug, IPI-926 [saridegib], also in combination with gemcitabine , which failed in the same ...
PharmiWeb.com (press release) ... Unit Kyoto University Hospital conducted a phase I study to look into the dosage effects of the Theracurmin® over 14 pancreatic and 2 biliary tract cancer patients who failed standard chemotherapy but were still on standard gemcitabine -based ...
Daily Markets (press release) This trial will be the seventh randomized Phase 2 clinical trial evaluating OGX-427 in the treatment of advanced cancers and will investigate whether adding OGX-427 to gemcitabine and carboplatin therapy can extend progression-free survival (PFS) ... and more »
OncLive The FDA has granted priority review to nab-paclitaxel (Abraxane) in combination with gemcitabine for the first-line treatment of patients with metastatic pancr...
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
